Eric Halioua | President & Chief Executive Officer
PDC*line pharma SA

Serial entrepreneur that combines strong strategic, technological and managerial experience with proven track record of deal-making and fund-raising. During my career I achieved together with my different teams to bring four drug candidates from research to the clinics (up to phase IIb). Overall, I have raised, as of now, a total of more than €170 million from VCs and strategic partners in Europe, USA, Japan and Korea and have had numerous successes in the sale and initial public offering of biotechnology companies. I am President and CEO of the biotechnology company PDC-Line Pharma and board member of Essenscia (Bio.be) and the biotech company Ergosuture. I am as well Managing Director of the strategic consulting company CarKath sprl. I was president of the board of  Cell Matters (bought by Cryoport) and a Board Member of the French biotechnology company Vivalis/Valneva, the Belgian companies Bioxodes, the Health Cluster of Wallonia BIOWIN and the industrial association European Biotechnology Entreprises (EBE). I have been as well CEO of Promethera Biosciences/Cellaïon and co-Inventor of the first worldwide GMP approved mobile manufacturing unit for cell therapy (WO 2014049151 A). I worked for 12 years as a Principal in the Healthcare and Life Sciences Practice of Arthur D. Little where I led work in the areas of strategy, M&A and technology & innovation management.  I am co-founder of 4 biotechnology companies called Myosix, Murigenetics, Digital-Orthopaedics and HairClone. 
• Myosix is a tissue engineering company specialising in musculoskeletal cells culture used in the regeneration of the heart muscle. The company has been bought by Genzyme mid-2002.
• Murigenetics is a Biotechnology company developing therapies for genetic disorders.
• Digital Orthopaedics is a Digital Health company providing access to a comprehensive Clinical Decision Support System for musculoskeletal pathologies. The company was selected as part of Dassault Systèmes 3DExperienceLab startup accelerator.
• HairClone is a Biotechnology company developing cell based hair treatments and Follicle Banking Service. I worked for IsoHealthcare Group (eventually acquired by the Monitor Group) as a Senior Consultant where I focused on leading healthcare and life sciences issues. I also worked as a strategic marketing Manager for the “Centre Européen de Bioprospective” and as project leader in the corporate R&D centre of Zeneca in UK.